Chris Senanayake is Director of Shuttle Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 2,791 shares of SHPH, which is worth approximately $1,814. The most recent transaction as insider was on Dec 29, 2022, when has been sold 1,626 shares (Common Stock) at a price of $1.6 per share, resulting in proceeds of $2,601. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.79K
0% 3M change
0% 12M change
Total Value Held $1,814

Chris Senanayake Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2022
SELL
Open market or private sale
$2,601 $1.6 p/Share
1,626 Reduced 36.81%
2,791 Common Stock
CS

Chris Senanayake

Director
Gaithersburg, MD

Track Institutional and Insider Activities on SHPH

Follow Shuttle Pharmaceuticals Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SHPH shares.

Notify only if

Insider Trading

Get notified when an Shuttle Pharmaceuticals Holdings, Inc. insider buys or sells SHPH shares.

Notify only if

News

Receive news related to Shuttle Pharmaceuticals Holdings, Inc.

Track Activities on SHPH